According to GlobalData’s medical device pipeline database, 70 Cartilage Repair devices are in various stages of development globally. GlobalData’s report Cartilage Repair provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 56 are in active development, while the remaining 15 are in an inactive stage of development. There are 36 products in the early stages of development, and the remaining 20 are in the late stages of development.
Cartilage Repair procedures aim to regenerate, restore or replace articular cartilage to reduce joint pain and to prevent the development of arthritis. Cartilage Repair interventions can occur early in the spectrum of joint damage and offer an opportunity for patients to delay or altogether avoid needing total joint replacement surgery. Articular cartilage damage generally occurs via two main routes, sports-related and traumatic injury as well as through inflammatory arthropathies. There are several approaches employed to treat chondral lesions (cartilage damage) in the joints. The subsegments covered are: Platelet-Rich Plasma (PRP) Injection, Extracellular Matrix Implants, Intact Tissue Implants, and Marrow Stimulation (Microfracture).
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Cartilage Repair pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Cartilage Repair devices. Overall, most of these Cartilage Repair pipeline devices are being developed by private entities.
Key players involved in the active development of Cartilage Repair include Sparta Biomedical, Hyalex Orthopaedics, Aesculap Biologics, Rosivo, Ruilin Biomedical Nanjing, Vericel, Regentis Biomaterials, Zimmer Biomet, Royal College of Surgeons Ireland and 3D Bio.
For a complete picture of the developmental pipeline for Cartilage Repair devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.